Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ: EXAS )

49.26 -0.25 (-0.50%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,341,342
Open 49.82
Bid (Size) 47.70 (1)
Ask (Size) 49.32 (20)
Prev. Close 49.51
Today's Range 48.76 - 50.98
52wk Range 40.62 - 79.62
Shares Outstanding 171,948,769
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's Going On With Cancer Diagnostic Firm Guardant Health On Friday?
Guardant Health beat Q4 estimates with a smaller EPS loss and strong revenue growth. Analysts raised price targets, citing momentum and solid financials. 
Via Benzinga
Expert Outlook: Exact Sciences Through The Eyes Of 7 Analysts
Via Benzinga

Performance

YTD
-13.47%
-13.47%
1 Month
-10.09%
-10.09%
3 Month
-6.90%
-6.90%
6 Month
-17.49%
-17.49%
1 Year
-17.20%
-17.20%

More News

Read More
Why Exact Sciences (EXAS) Shares Are Trading Lower Today
Via StockStory
Palantir Rally Loses Steam, Walmart Outlook Disappoints: What's Driving Markets Thursday?
Via Benzinga
Earnings Scheduled For February 19, 2025
Via Benzinga
Forecasting The Future: 19 Analyst Projections For Exact Sciences
Via Benzinga
Exact Sciences (EXAS) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Exact Sciences Stock Slides On Q4 Earnings: The Details
Via Benzinga
Exact Sciences’s (NASDAQ:EXAS) Q4: Beats On Revenue
Via StockStory
Exact Sciences Announces Fourth Quarter 2024 Results
From Exact Sciences Corp.
Via Business Wire
Trump Calls For More Tariffs, Federal Reserve Minutes On Deck: What's Driving Markets Wednesday?
Via Benzinga
Topics Economy Government World Trade
Exposures Interest Rates Political Tariff
Exact Sciences (EXAS) Reports Earnings Tomorrow: What To Expect
Via StockStory
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Exact Sciences Schedules Fourth Quarter 2024 Earnings Call
From Exact Sciences Corp.
Via Business Wire
Exact Sciences Demonstrates Leadership in Cancer Innovation with New Data on Screening and Molecular Residual Disease at 2025 ASCO GI Symposium
From Exact Sciences Corp.
Via Business Wire
(EXAS) - Analyzing Exact Sciences's Short Interest
Via Benzinga
What 19 Analyst Ratings Have To Say About Exact Sciences
Via Benzinga
New Evidence Validates Oncodetect's™ Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients
From Exact Sciences Corp.
Via Business Wire
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone
Via Investor's Business Daily
Exact Sciences Stock Drops 12% Over Four Days. 'What Is Going On?'
Via Investor's Business Daily
2 Healthcare Stocks to Buy Hand Over Fist in January
Via The Motley Fool
Exact Sciences Sparks Analyst Optimism Amid Competitive Multi-Cancer Test Market
Via Benzinga
Exact Sciences Announces Preliminary Fourth Quarter 2024 Results
From Exact Sciences Corp.
Via Business Wire
Exact Sciences to Participate in J.P. Morgan Healthcare Conference
From Exact Sciences Corp.
Via Business Wire
Rivian Automotive, Rocket Lab And Moderna Are Among Top 10 Large-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.